In PD, the progression of pathological α-synuclein spreading in a prion-like manner [19, 81], schematized by the Braak stages [8], correlates with the appearance of signs and symptoms [57] and presents a major obstacle to current therapy [81]. Here, SNCA is linked to Parkinson disease.